Home
NVO
NVO News

Latest Novo Nordisk A/S (NVO) News on December 26, 2024

Elon Musk's Weight-Loss Secret Shakes Up Pharma Giants

GuruFocus.com

an hour ago

Elon Musk's Weight-Loss Secret Shakes Up Pharma Giants

Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy?

Motley Fool

2 hours ago

Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy?

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

a day ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Jim Cramer Says Novo Nordisk A/S (NVO) Can’t Exceed Eli Lilly

Insider Monkey

a day ago

Jim Cramer Says Novo Nordisk A/S (NVO) Can’t Exceed Eli Lilly

Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst

Yahoo Finance Video

a day ago

Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst

Novo Nordisk (NVO) Stock Drops Despite Market Gains: Important Facts to Note

Zacks

2 days ago

Novo Nordisk (NVO) Stock Drops Despite Market Gains: Important Facts to Note

What's next for GLP-1 weight-loss drugs in 2025?

Yahoo Finance Video

2 days ago

What's next for GLP-1 weight-loss drugs in 2025?

3 biggest catalysts expected for healthcare in 2025

Yahoo Finance Video

2 days ago

3 biggest catalysts expected for healthcare in 2025

Retail investors buy Novo dip after disappointing weight-loss drug data

Reuters

2 days ago

Retail investors buy Novo dip after disappointing weight-loss drug data

Novo Nordisk Stock Plunges 18% in a Week: What Should Investors Do?

Zacks

2 days ago

Novo Nordisk Stock Plunges 18% in a Week: What Should Investors Do?

Novo gets the green light for once-daily haemophilia drug following setbacks

Pharmaceutical Technology

2 days ago

Novo gets the green light for once-daily haemophilia drug following setbacks

Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength.

Barrons.com

3 days ago

Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength.

European Stocks Edge Higher as Novo Nordisk Jumps From 2023 Low

Bloomberg

3 days ago

European Stocks Edge Higher as Novo Nordisk Jumps From 2023 Low

Xerox-Lexmark, Novo Nordisk, News Corp: 3 stories in focus

Yahoo Finance Video

3 days ago

Xerox-Lexmark, Novo Nordisk, News Corp: 3 stories in focus

NVO Stock Plunges as Obesity Drug CagriSema Misses Target in Phase III

Zacks

3 days ago

NVO Stock Plunges as Obesity Drug CagriSema Misses Target in Phase III

Lilly's Zepbound Receives FDA Approval for Sleep Apnea

Zacks

3 days ago

Lilly's Zepbound Receives FDA Approval for Sleep Apnea

Hot Obesity Drug Market Will Keep Investors Gripped Next Year

Bloomberg

3 days ago

Hot Obesity Drug Market Will Keep Investors Gripped Next Year

Asian, European Markets Gain as Novo Nordisk Shines

Barrons.com

3 days ago

Asian, European Markets Gain as Novo Nordisk Shines

Is Merck the Next Big Weight-Loss Stock?

Motley Fool

4 days ago

Is Merck the Next Big Weight-Loss Stock?

Novo obesity data positive for Eli Lilly and Amgen, says UBS

TipRanks

5 days ago

Novo obesity data positive for Eli Lilly and Amgen, says UBS

Jefferies sees Novo dropping ‘at least’ 10%-15% on obesity data

TipRanks

5 days ago

Jefferies sees Novo dropping ‘at least’ 10%-15% on obesity data

Weight loss seen with Novo’s CagriSema weaker than expected, says BofA

TipRanks

5 days ago

Weight loss seen with Novo’s CagriSema weaker than expected, says BofA

3 Fantastic Stocks That Could Enjoy a Santa Claus Rally

Motley Fool

5 days ago

3 Fantastic Stocks That Could Enjoy a Santa Claus Rally

Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

Motley Fool

5 days ago

Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

Morningstar Research

6 days ago

Analyst Report: Novo Nordisk A/S

Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge.

Investor's Business Daily

6 days ago

Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge.

Stock Market Today: Dow Jones, Other Indexes Rebound But Trim Gains; Nvidia Climbs After Bullish Report (Live Coverage)

Investor's Business Daily

6 days ago

Stock Market Today: Dow Jones, Other Indexes Rebound But Trim Gains; Nvidia Climbs After Bullish Report (Live Coverage)

Morningstar Research

6 days ago

Analyst Report: Novo Nordisk A/S

MT Newswires

6 days ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

Top Stock Movers Now: Carnival, US Steel, Occidental Petroleum, and More

Investopedia

6 days ago

Top Stock Movers Now: Carnival, US Steel, Occidental Petroleum, and More

Novo’s Obesity Shot Shortfall Shows Danger of Promising Too Much

Bloomberg

6 days ago

Novo’s Obesity Shot Shortfall Shows Danger of Promising Too Much

Stocks suffer as Trump calls for US shutdown to ‘begin now’

The Telegraph

6 days ago

Stocks suffer as Trump calls for US shutdown to ‘begin now’

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up

Motley Fool

6 days ago

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up

Novo Nordisk stock plunges on obesity shot trial results

Yahoo Finance Video

6 days ago

Novo Nordisk stock plunges on obesity shot trial results

MT Newswires

6 days ago

Amgen, Eli Lilly, Viking Therapeutics Shares Rise Pre-Bell After Novo Nordisk's Obesity Treatment Falls Short of Expectations

Novo Nordisk Stock Crashes on Obesity Drug Data. It’s a Win for Eli Lilly.

Barrons.com

6 days ago

Novo Nordisk Stock Crashes on Obesity Drug Data. It’s a Win for Eli Lilly.

Novo Crashes 20% After New Obesity Drug Misses Forecasts. Lilly, Viking, Amgen Jump.

Investor's Business Daily

6 days ago

Novo Crashes 20% After New Obesity Drug Misses Forecasts. Lilly, Viking, Amgen Jump.

November PCE, govt. shutdown looms, Novo Nordisk: 3 Things

Yahoo Finance Video

6 days ago

November PCE, govt. shutdown looms, Novo Nordisk: 3 Things

MT Newswires

6 days ago

Sector Update: Health Care Stocks Mixed Premarket Friday

MT Newswires

6 days ago

Sector Update: Health Care

MT Newswires

6 days ago

Top Premarket Decliners

In weight loss battle, Novo and Lilly face growing offensive from licensed copies

Reuters

7 days ago

In weight loss battle, Novo and Lilly face growing offensive from licensed copies

Novo Is Ready to Ramp Up GLP-1 Manufacturing Following $11B Factory Deal

Barrons.com

7 days ago

Novo Is Ready to Ramp Up GLP-1 Manufacturing Following $11B Factory Deal

IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List

Investor's Business Daily

7 days ago

IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List

FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next

Yahoo Finance

7 days ago

FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next

Novo Nordisk A/S (NVO) Fell as its Weight Loss Drug Faced Supply Constraints

Insider Monkey

7 days ago

Novo Nordisk A/S (NVO) Fell as its Weight Loss Drug Faced Supply Constraints

Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug

Zacks

7 days ago

Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug

Got $250? 2 Healthcare Stocks to Buy and Hold Forever

Motley Fool

7 days ago

Got $250? 2 Healthcare Stocks to Buy and Hold Forever

This Is Huge News for Eli Lilly Investors

Motley Fool

7 days ago

This Is Huge News for Eli Lilly Investors

MT Newswires

8 days ago

Novo Nordisk Says Danish Studies Didn't Show Semaglutide's Link With Eye Disease

Elon Musk, RFK Jr., Dr. Oz, and the coming clash over Ozempic

Yahoo Finance

8 days ago

Elon Musk, RFK Jr., Dr. Oz, and the coming clash over Ozempic

MT Newswires

8 days ago

Correction: Novo Nordisk Controlling Shareholder Completes $16.5 Billion Catalent Buyout

MT Newswires

8 days ago

Novo Nordisk Controlling Shareholder Completes $16.5 Billion Catalent Buyout

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed

GlobeNewswire

8 days ago

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed

Ozempic Dethroned? A Head-to-Head Study Confirms This Company Has the Best Weight Loss Drug

Motley Fool

8 days ago

Ozempic Dethroned? A Head-to-Head Study Confirms This Company Has the Best Weight Loss Drug

Novo Nordisk invests $1.2bn in new Denmark facility

Pharmaceutical Technology

9 days ago

Novo Nordisk invests $1.2bn in new Denmark facility

NVO to Invest $1.2B in New Rare Disease Drugs Facility in Denmark

Zacks

9 days ago

NVO to Invest $1.2B in New Rare Disease Drugs Facility in Denmark

Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

Zacks

9 days ago

Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

Is Novo Nordisk A/S (NVO) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Insider Monkey

9 days ago

Is Novo Nordisk A/S (NVO) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Novo Nordisk’s Hiring Binge Leaves Danish Firms Starved of Labor

Bloomberg

9 days ago

Novo Nordisk’s Hiring Binge Leaves Danish Firms Starved of Labor

Novo’s New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way.

Barrons.com

10 days ago

Novo’s New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way.

MT Newswires

10 days ago

Sector Update: Health Care Stocks Decline Monday Afternoon

MT Newswires

10 days ago

Top Midday Stories: Honeywell Mulls Separation of Aerospace Business; Starbucks Expands Parental Leave for US Store Workers

Novo Nordisk (NVO) To Diversify Revenue Streams With $1.2bn Investment In Denmark

Insider Monkey

10 days ago

Novo Nordisk (NVO) To Diversify Revenue Streams With $1.2bn Investment In Denmark

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

10 days ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent

Benzinga

10 days ago

Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent

Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?

Investor's Business Daily

10 days ago

Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?

Novo Nordisk A/S - share repurchase programme

GlobeNewswire

10 days ago

Novo Nordisk A/S - share repurchase programme

MT Newswires

10 days ago

Catalent Acquisition by Novo Holdings Nearly Complete After Regulatory Hurdles Cleared

MT Newswires

10 days ago

Novo Nordisk to Invest $1.2 Billion in Danish Production Facility

The Weight-Loss Drug Market Is Heading for a Reckoning This Week. What to Expect.

Barrons.com

10 days ago

The Weight-Loss Drug Market Is Heading for a Reckoning This Week. What to Expect.

Novo Nordisk invests $1.2 billion in new rare disease drugs plant in Denmark

Reuters

10 days ago

Novo Nordisk invests $1.2 billion in new rare disease drugs plant in Denmark

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark

GlobeNewswire

10 days ago

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark

Nvidia, GM, Walmart, Palantir, Tesla, Meta, and others battle this Yahoo Finance awards season

Yahoo Finance

11 days ago

Nvidia, GM, Walmart, Palantir, Tesla, Meta, and others battle this Yahoo Finance awards season

Did Eli Lilly Just Say "Checkmate" to Novo Nordisk?

Motley Fool

11 days ago

Did Eli Lilly Just Say "Checkmate" to Novo Nordisk?

Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say

Reuters

12 days ago

Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

GlobeNewswire

12 days ago

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

Novo Nordisk (NVO) Stock Moves -1.53%: What You Should Know

Zacks

13 days ago

Novo Nordisk (NVO) Stock Moves -1.53%: What You Should Know

Novo Nordisk's Ozempic reportedly linked to vision loss in new study

Yahoo Finance Video

13 days ago

Novo Nordisk's Ozempic reportedly linked to vision loss in new study

Ozempic could be linked to a common cause of sudden blindness, study finds

Quartz

13 days ago

Ozempic could be linked to a common cause of sudden blindness, study finds

Ozempic Link to Rare Vision Loss Risk Confirmed in Study

Bloomberg

13 days ago

Ozempic Link to Rare Vision Loss Risk Confirmed in Study

MT Newswires

13 days ago

Novo Nordisk Receives Positive EMA Opinion to Update Ozempic Label With Risk Reduction of Kidney Disease-Related Events

NVO Gets Positive CHMP Opinion in EU for Ozempic Expanded Use in CKD

Zacks

13 days ago

NVO Gets Positive CHMP Opinion in EU for Ozempic Expanded Use in CKD

Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling.

Barrons.com

13 days ago

Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling.

3 Growth Stocks That Can Be No-Brainer Buys in 2025

Motley Fool

13 days ago

3 Growth Stocks That Can Be No-Brainer Buys in 2025

Here’s Why Novo Nordisk A/S (NVO) Fell in Q3

Insider Monkey

14 days ago

Here’s Why Novo Nordisk A/S (NVO) Fell in Q3

Telehealth Firm Ro Partners With Eli Lilly to Boost Access to Obesity Drug Zepbound

Benzinga

14 days ago

Telehealth Firm Ro Partners With Eli Lilly to Boost Access to Obesity Drug Zepbound

Novo Nordisk A/S: European regulatory authority adopts positive opinion for an update of the Ozempic® label to reflect risk reduction of kidney disease-related events

GlobeNewswire

14 days ago

Novo Nordisk A/S: European regulatory authority adopts positive opinion for an update of the Ozempic® label to reflect risk reduction of kidney disease-related events

What can't weight-loss meds do? Eli Lilly is going to test Zepbound as a treatment for addiction

Quartz

15 days ago

What can't weight-loss meds do? Eli Lilly is going to test Zepbound as a treatment for addiction

Ro partners with Eli Lilly to expand access to Zepbound vials

Yahoo Finance

15 days ago

Ro partners with Eli Lilly to expand access to Zepbound vials

MT Newswires

15 days ago

Evotec, Novo Nordisk Drug Discovery Accelerator Selects First Three Projects for Cardiometabolic Conditions

GLP-1 compounding is still in limbo. Will the FDA leave it for the next administration?

Pharma Voice

15 days ago

GLP-1 compounding is still in limbo. Will the FDA leave it for the next administration?

Warning: This Skyrocketing Stock Has a Hidden Risk

Motley Fool

16 days ago

Warning: This Skyrocketing Stock Has a Hidden Risk

Novo Nordisk Just Got One Step Closer to Resolving Wegovy Supply Issue

Barrons.com

17 days ago

Novo Nordisk Just Got One Step Closer to Resolving Wegovy Supply Issue

PFE or NVO: Which Is the Better Value Stock Right Now?

Zacks

17 days ago

PFE or NVO: Which Is the Better Value Stock Right Now?

Novo Nordisk A/S - share repurchase programme

GlobeNewswire

17 days ago

Novo Nordisk A/S - share repurchase programme

New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point

Zacks

17 days ago

New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point

Argus Research

17 days ago

Daily Spotlight: India Anticipated Growth Leader in 2025

Eli Lilly Stock Just Got Even Sweeter. Here's Why It's Worth Buying Now

Motley Fool

17 days ago

Eli Lilly Stock Just Got Even Sweeter. Here's Why It's Worth Buying Now

The Zacks Analyst Blog Eli Lilly, Novo Nordisk's Amgen and Viking Therapeutics

Zacks

17 days ago

The Zacks Analyst Blog Eli Lilly, Novo Nordisk's Amgen and Viking Therapeutics

Share on Social Networks: